Alvotech (ALVO) Stock

Alvotech (ALVO) is a Healthcare stock trading at $3.92 (as of 2026-06-18), with a market capitalization of $979.75M and a trailing P/E of 39.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

I can’t produce a compliant description yet because the SEC 10-K “Business” (Item 1) text for Alvotech wasn’t provided. Please paste the relevant Item 1 Business section so I can base a 1–2 sentence (~45 words) company description strictly on that primary source.

Valuation — source: SEC EDGAR (first-party)
Price$3.92
Market Cap$979.75M
P/E Ratio39.2
Price / Book-4.30
Price / Sales2.09
DCF Value (model)$-6.23
DCF Upside vs Price-258.9%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$586.32M
Net Margin4.8%
Return on Equity-9.8%
Debt / Equity-4.44
Current Ratio1.89
Revenue Growth (YoY)19.7%
EPS Growth (YoY)-111.5%
Financial Health — source: SEC EDGAR
Piotroski F-Score2/9 (weak)
Valuation vs Sector & Industry
Stock P/E39.2
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector87.0%
vs Industry127.1%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($22.56M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOVilhelm Robert Wessman
Employees1,012
CountryIS
IPO Date2022-06-16

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • BioCryst Pharmaceuticals, Inc. (BCRX)
  • Capricor Therapeutics, Inc. (CAPR)
  • Trevi Therapeutics, Inc. (TRVI)
  • Agios Pharmaceuticals, Inc. (AGIO)
  • Biohaven Ltd. (BHVN)
  • uniQure N.V. (QURE)
  • Innoviva, Inc. (INVA)
  • Atai Beckley N.V (ATAI)
ALVO earnings history · ALVO institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.